Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model
We assessed the torsadogenic effects of a novel remyelinating drug clemastine for multiple sclerosis using an in vivo proarrhythmia model of acute atrioventricular block rabbit, since the drug has been demonstrated to suppress the human ether-á-go-go related gene (hERG) K+ channels. Bradycardia was...
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Elsevier
2020-11-01
|
| Serie: | Journal of Pharmacological Sciences |
| Ämnen: | |
| Länkar: | http://www.sciencedirect.com/science/article/pii/S1347861320300839 |